Sensitization of resistant lymphoma cells to irradiation-induced apoptosis by the death ligand TRAIL

被引:113
作者
Belka, C
Schmid, B
Marini, P
Durand, E
Rudner, J
Faltin, H
Bamberg, M
Schulze-Osthoff, K
Budach, W
机构
[1] Univ Tubingen, Dept Radiat Oncol, D-72076 Tubingen, Germany
[2] Univ Munster, Inst Expt Dermatol, Dept Immunol & Cell Biol, D-48149 Muenster, Germany
关键词
TRAIL; radiation; caspase-8; Bcl-2; apoptosis;
D O I
10.1038/sj.onc.1204318
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
A combination of antitumor approaches acting on different death pathways seems ideal for increasing therapeutic responses, especially when defined resistance mechanisms interfere with individual cellular processes. Apoptosis pathways triggered by ionizing radiation (XRT) and the death ligand TRAIL were analysed in Jurkat lymphoma cells. Both induced the activation of caspase-8, caspase-3, BID and mitochondrial potential loss, TRAIL induced apoptosis required caspase-8, whereas it was not essential for radiation induced apoptosis. The inhibition of mitochondrial damage by Bcl-2 abrogated XRT induced apoptosis and caspase activation, but only marginally attenuated TRAIL induced cell death. The combined treatment with TRAIL and XRT exerted additive apoptotic effects in control cells, whereas highly synergistic effects occurred in cells overexpressing Bcl-2. In addition, a strong effect of TRAIL on radiation induced clonogenic cell death was found. In conclusion, TRAIL seems to be of high potential value for a combination with ionizing radiation in tumor therapy.
引用
收藏
页码:2190 / 2196
页数:7
相关论文
共 29 条
[1]   INCREASING THE SUSCEPTIBILITY OF THE RAT 208F FIBROBLAST CELL-LINE TO RADIATION-INDUCED APOPTOSIS DOES NOT ALTER ITS CLONOGENIC SURVIVAL DOSE - RESPONSE [J].
ALDRIDGE, DR ;
ARENDS, MJ ;
RADFORD, IR .
BRITISH JOURNAL OF CANCER, 1995, 71 (03) :571-577
[2]   Safety and antitumor activity of recombinant soluble Apo2 ligand [J].
Ashkenazi, A ;
Pai, RC ;
Fong, S ;
Leung, S ;
Lawrence, DA ;
Masters, SA ;
Blackie, C ;
Chang, L ;
McMurtrey, AE ;
Hebert, A ;
DeForge, L ;
Koumenis, IL ;
Lewis, D ;
Harris, L ;
Bussiere, J ;
Koeppen, H ;
Shahrokh, Z ;
Schwall, RH .
JOURNAL OF CLINICAL INVESTIGATION, 1999, 104 (02) :155-162
[3]   EXPRESSION OF THE BCL-2 GENE FAMILY IN NORMAL AND MALIGNANT BREAST-TISSUE - LOW BAX-ALPHA EXPRESSION IN TUMOR-CELLS CORRELATES WITH RESISTANCE TOWARDS APOPTOSIS [J].
BARGOU, RC ;
DANIEL, PT ;
MAPARA, MY ;
BOMMERT, K ;
WAGENER, C ;
KALLINICH, B ;
ROYER, HD ;
DORKEN, B .
INTERNATIONAL JOURNAL OF CANCER, 1995, 60 (06) :854-859
[4]   Differential role of caspase-8 and BID activation during radiation- and CD95-induced apoptosis [J].
Belka, C ;
Rudner, J ;
Wesselborg, S ;
Stepczynska, A ;
Marini, P ;
Lepple-Wienhues, A ;
Faltin, H ;
Bamberg, M ;
Budach, W ;
Schulze-Osthoff, K .
ONCOGENE, 2000, 19 (09) :1181-1190
[5]   FADD, A NOVEL DEATH DOMAIN-CONTAINING PROTEIN, INTERACTS WITH THE DEATH DOMAIN OF FAS AND INITIATES APOPTOSIS [J].
CHINNAIYAN, AM ;
OROURKE, K ;
TEWARI, M ;
DIXIT, VM .
CELL, 1995, 81 (04) :505-512
[6]   Increased expression of death receptors 4 and 5 synergizes the apoptosis response to combined treatment with etoposide and TRAIL [J].
Gibson, SB ;
Oyer, R ;
Spalding, AC ;
Anderson, SM ;
Johnson, GL .
MOLECULAR AND CELLULAR BIOLOGY, 2000, 20 (01) :205-212
[7]  
Gong BD, 2000, CANCER RES, V60, P5754
[8]  
GRECO WR, 1995, PHARMACOL REV, V47, P331
[9]   COMPARATIVE HUMAN CELLULAR RADIOSENSITIVITY .3. GAMMA-RADIATION SURVIVAL OF CULTURED SKIN FIBROBLASTS AND RESTING T-LYMPHOCYTES FROM THE PERIPHERAL-BLOOD OF THE SAME INDIVIDUAL [J].
GREEN, MHL ;
ARLETT, CF ;
COLE, J ;
HARCOURT, SA ;
PRIESTLEY, A ;
WAUGH, APW ;
STEPHENS, G ;
BEARE, DM ;
BROWN, NAP ;
SHUNSHIN, GA .
INTERNATIONAL JOURNAL OF RADIATION BIOLOGY, 1991, 59 (03) :749-765
[10]   Prognostic significance of BCL-2 expression and bcl-2 major breakpoint region rearrangement in diffuse large cell non-Hodgkin's lymphoma: A British National Lymphoma Investigation Study [J].
Hill, ME ;
MacLennan, KA ;
Cunningham, DC ;
Hudson, BV ;
Burke, M ;
Clarke, P ;
DiStefano, F ;
Anderson, L ;
Hudson, GV ;
Mason, D ;
Selby, P ;
Linch, DC .
BLOOD, 1996, 88 (03) :1046-1051